Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PRA Expands Trial Capabilities in Asia | Contract Pharma

What are you searching for?

Sign in
Breaking News

PRA Expands Trial Capabilities in Asia

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PRA Taiwan, a subsidiary of PRA International, has entered a strategic partnership with LSK Global Pharma Services and Mediscience Planning for the joint management of multinational clinical trials in Asia as well as related services, such as study monitoring and data management.

The partnership adds to PRA’s capabilities in Asia with regulatory intelligence and investigator sites in Japan through Mediscience, and in South Korea through LSK.

“We are very pleased to broaden our Asian capabilities through this partnership,” said Susan Stansfield, executive vice president of product registration for Europe, Africa and Asia-Pacific. “Through this collaboration, we are strongly positioned to meet the growing demand for pan-Asian clinical trials.”

“Formalizing our relationships with Mediscience and LSK is an important step for our company,” added Edward Ian, senior director of Clinical Operations, PRA – Asia Pacific. “This partnership will further improve our ability to promote and execute regional clinical trials in Japan, Taiwan, and Korea.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics